quotuptrend

642 results found.

Top Stocks matching your search for "quot uptrend"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Missling is being "patient" taking month... See more

Jan, 6, 2023

Abrahams sees ultimate approval as "very like... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 21, 2023

$TGTX next few weeks will be a good buying opportu... See more

Jan, 16, 2023

$TGTX "4 Stories of Living with Multiple Scle... See more

Image with triangles

Divihomes is Now Live

Check out our new advanced search tool that can help you find the best home services in your area.

Search & Match

Instant Communication

Phone Image with DiviHomes website

Unbiased Reviews

100% Free

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
OUST

Ouster Inc - Ordinary Shares - Class A

-49.79%

$1.74 - $0.87

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

$OUST "Our sensor-agnostic solutions provide... See more

Jan, 24, 2023

"Digital lidar never stops improving – and do... See more

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 6, 2023

Missling is being "patient" taking months longer than any other company to analyze and release trial data (and then not actually releasing the full data set), so he's awesome.

Jan, 6, 2023

Abrahams sees ultimate approval as "very likely" and a favorable setup in Biogen shares.

Dec, 9, 2022

$AVXL George Perry stated, the Anavex drug is "revolutionary", as is uniquely good, no other drug has EVER increased cognition EVER.

Dec, 7, 2022

IMO, with their "rapid" label and test showing sustained improvement in cognition and daily living, it will be hard not to try Auvelity if you suffer from MDD.

Dec, 6, 2022

Value is what you get. "Revolutionary."

Dec, 6, 2022

The results are incredible and 50mg study with no side effects is spectacular."

Dec, 5, 2022

The information points clearly this is much better than "Aduhelm" or Lecanemab.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 21, 2023

$TGTX next few weeks will be a good buying opportunity for "risk on" assets imo.

Jan, 16, 2023

$TGTX "4 Stories of Living with Multiple Sclerosis" Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.

Dec, 30, 2022

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Dec, 29, 2022

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Dec, 26, 2022

Check it out below.""" 👇 Highly recommend everyone to follow them 💪 https://amazing-stocks-us.stockmarketus.net/

OUST

Ouster Inc - Ordinary Shares - Class A

-49.79%

$1.74 - $0.87

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

$OUST "Our sensor-agnostic solutions provide 3D models and real-time perception of intersections, roadways and more.

Jan, 24, 2023

"Digital lidar never stops improving – and doubling the range of our existing sensors while adding the OSDome is truly unprecedented, and is only possible with a digital architecture.

Jan, 18, 2023

"We come away more favorable on the upcoming merger, as both companies are focused on delivering lidar units to industrial markets," he said in a note to clients.

Jan, 17, 2023

"Digital lidar never stops improving – and doubling the range of our existing sensors while adding the OSDome is truly unprecedented, and is only possible with a digital architecture.

Jan, 14, 2023

"We come away more favorable on the upcoming merger, as both companies are focused on delivering lidar units to industrial markets," he said in a note to clients.

Jan, 13, 2023

"We come away more favorable on the upcoming merger, as both companies are focused on delivering lidar units to industrial markets," he said in a note to clients.

Jan, 11, 2023

"Digital lidar never stops improving – and doubling the range of our existing sensors while adding the OSDome is truly unprecedented, and is only possible with a digital architecture.